✦ LIBER ✦

The 3′ UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer

✍ Scribed by Athanassios Kotsinas; Konstantinos Evangelou; Maria Sideridou; George Kotzamanis; Constantinos Constantinides; Athanasios I. Zavras; Chester W. Douglass; Athanasios G. Papavassiliou; Vassilis G. Gorgoulis

Book ID: 116334551
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 165 KB
Volume: 259
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2007.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased NDRG1 Expression is Associated

Increased NDRG1 Expression is Associated with Advanced T Stages and Poor Vascularization in Non-small Cell Lung Cancer

✍ Chuifeng Fan, Juanhan Yu, Yang Liu, Hongtao Xu, Enhua Wang 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 589 KB

The prognostic significance of pretreatm

The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer

✍ Han, Ji-Youn; Choi, Byung Gil; Choi, Ji Young; Lee, Sung Young; Ju, So Young 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Insulin-like Growth Factor (IGF) I Down-

Insulin-like Growth Factor (IGF) I Down-Regulates Type 1 IGF Receptor (IGF 1R) and Reduces the IGF I Response in A549 Non-Small-Cell Lung Cancer and Saos-2/B-10 Osteoblastic Osteosarcoma Cells

✍ Katalin Tisa Bostedt; Christoph Schmid; Claudia Ghirlanda-Keller; Robert Olie; K 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Differential expression of survivin-2B a

Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)

✍ Ling, Xiang; Yang, Jie; Tan, DongFeng; Ramnath, Nithya; Younis, Tallal; Bundy, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Immunotherapy with the use of tumor-infi

Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study

✍ Giovanni B. Ratto; Giovanni Melioli; Paolo Zino; Carlo Mereu; Sandro Mirabelli; 📂 Article 📅 1995 🏛 CTSNet 🌐 English ⚖ 553 KB

P-484 Synchronous overexpression of epid

P-484 Synchronous overexpression of epidermal growth factor receptor and HER2-NEU is a predictor of poor outcome in patients with stage I non-small cell lung cancer

✍ Onn, Amir; Correa, Arlene M.; Gilcrease, Michael; Massarelli, Erminia; Bucana, C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB